Corvus Pharmaceuticals CRVS Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Corvus Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corvus Pharmaceuticals's earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corvus Pharmaceuticals's earnings yield?
- Corvus Pharmaceuticals (CRVS) reported earnings yield of -3.6% in Q1 2026.
- How has Corvus Pharmaceuticals's earnings yield changed year-over-year?
- Corvus Pharmaceuticals's earnings yield increased by 81.2% year-over-year, from -19.1% to -3.6%.
- What is the long-term trend for Corvus Pharmaceuticals's earnings yield?
- Over 5 years (2020 to 2025), Corvus Pharmaceuticals's earnings yield has grown at a -6.0% compound annual growth rate (CAGR), from -3.6% to -2.7%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.